<DOC>
	<DOCNO>NCT00139295</DOCNO>
	<brief_summary>This clinical study investigate safety efficacy hylastan treating patient symptomatic osteoarthritis ( OA ) knee .</brief_summary>
	<brief_title>Comparison Hylastan Methylprednisolone Acetate Patients With Symptomatic Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Diagnosed OA knee Have try sufficiently help conservative treatment , weight reduction pain medication Prior concomitant treatment would impede measurement safety efficacy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>musculoskeletal</keyword>
	<keyword>osteoarthritis knee</keyword>
</DOC>